General Incorporated Association Pharma Valley Project Supporting Organization

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 6

Loading Chart...

17 inventors (with patents filed for the assignee):

Akira Asai (4 out of 5 patents)

Naohisa Ogo (4 out of 5 patents)

Daisuke Muraoka (2 out of 4 patents)

4. Hiroshi Shiku (1 out of 24 patents)

5. Naozumi Harada (1 out of 5 patents)

6. Mai Ohba (1 out of 1 patent)

7. Takayuki Ando (1 out of 1 patent)

8. Yasuto Akiyama (1 out of 4 patents)

9. Osamu Takahashi (1 out of 39 patents)

10. Takumi Kawabe (1 out of 17 patents)

11. Takuji Sato (1 out of 7 patents)

12. Kenji Matsuno (1 out of 2 patents)

13. Ayumu Muroya (1 out of 1 patent)

14. Tadashi Ashizawa (1 out of 2 patents)

15. Tadashi Okawara (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 12209079 - IDO/TDO inhibitor (2025-01-28),

2. 11213538 - Agent for overcoming immunosuppression and use thereof (2022-01-04),

3. 11020371 - Anti-norovirus composition and utilization thereof (2021-06-01),

4. 8796320 - 1,3,4-Oxadiazole-2-carboxamide compound (2014-08-05),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#1 in Mishima

#7,590 in Japan

Mishima, Japan

General Incorporated Association Pharma Valley Project Supporting Organization

Forward Citations = 6

17 inventors:

Akira Asai (4 out of 5 patents)

Naohisa Ogo (4 out of 5 patents)

Daisuke Muraoka (2 out of 4 patents)

4. Hiroshi Shiku (1 out of 24 patents)

5. Naozumi Harada (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: General Incorporated Association Pharma Valley Project Supporting Organization. Retrieved from https://idiyas.com/company/general-association-pharma-valley-project-supporting-organization

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]